The case histories are reported of two patients with systemic lupus erythematosus (SLE) who developed fatal neurological involvement, each presenting with cerebeliar and brainstem signs. Neuro-pathological changes were confined to the cerebellum and brainstem, with clear evidence of a small vessel vasculopathy. The predominant histological abnormalities were multiple perivascular haemorrhages in one case and classical vasculitic changes in the other.
In the absence of an alternative diagnosis, the neurological features were attributed to SLE and/or antiphospholipid syndrome (APS). Although a thromboembolic aetiology could not be excluded, this was thought unlikely. Intravenous anticoagulation was therefore considered inappropriate, but she was maintained on subcutaneous heparin. Treatment with alternating daily intravenous methylprednisolone (1 gm) and cyclophosphamide (500 mg) was started, but after 11 days a dramatic and rapid deterioration occurrred. She developed tetraplegia, bulbar palsy, loss of sphincter control and required temporary ventilation. Enteral prednisolone was given (60 mg/day) together with intravenous immunoglobulin and alternate day plasmapheresis was performed. Neurological signs remained unchanged, but she became increasingly depressed and withdrawn. An The fresh brain (1580 gm) was swollen and surgical drains were present. The right cerebellar hemisphere contained an area of softening which extended into the right side of the pons. This region was the centre of striking histological abnormalities that extended into the midbrain and medulla. Collections of polymorph neutrophils and small haemorrhages in infarcted parenchyma surrounded many small blood vessels, which showed prominent vasculitic changes with fibrinoid necrosis (fig 2) . Most of these vessels were small venules and several vascular territories were affected, W.*I -' 'w 'F "n @* * ' @"f, Based predominantly on uncontrolled, retrospective and anecdotal data, the treatment of NP-SLE remains largely empirical.' Case 1 deteriorated and died despite a combination of treatments, which included high dose immunosuppression. In case 2, the diagnosis of NP-SLE was considered only at necropsy.
Detailed histopathological information from the brain in NP-SLE is rarely available. Both cases were unusual in that the clinical manifestations and distribution of pathological abnormalities were each confined to the cerebellum and brainstem, the reasons for which remain obscure. These cases demonstrate two distinct forms of small vessel vasculopathy seen in NP-SLE and suggest that this type of lesion may underlie severe forms of the disease. 
